237 related articles for article (PubMed ID: 17706946)
1. Sensitivity of the hypothalamic paraventricular nucleus to the locomotor-activating effects of neuromedin U in obesity.
Novak CM; Zhang M; Levine JA
Brain Res; 2007 Sep; 1169():57-68. PubMed ID: 17706946
[TBL] [Abstract][Full Text] [Related]
2. Neuromedin U in the paraventricular and arcuate hypothalamic nuclei increases non-exercise activity thermogenesis.
Novak CM; Zhang M; Levine JA
J Neuroendocrinol; 2006 Aug; 18(8):594-601. PubMed ID: 16867180
[TBL] [Abstract][Full Text] [Related]
3. Central orexin sensitivity, physical activity, and obesity in diet-induced obese and diet-resistant rats.
Novak CM; Kotz CM; Levine JA
Am J Physiol Endocrinol Metab; 2006 Feb; 290(2):E396-403. PubMed ID: 16188908
[TBL] [Abstract][Full Text] [Related]
4. Neuromedin U receptor 2 knockdown in the paraventricular nucleus modifies behavioral responses to obesogenic high-fat food and leads to increased body weight.
Benzon CR; Johnson SB; McCue DL; Li D; Green TA; Hommel JD
Neuroscience; 2014 Jan; 258():270-9. PubMed ID: 24269937
[TBL] [Abstract][Full Text] [Related]
5. Regulation of motivation for food by neuromedin U in the paraventricular nucleus and the dorsal raphe nucleus.
McCue DL; Kasper JM; Hommel JD
Int J Obes (Lond); 2017 Jan; 41(1):120-128. PubMed ID: 27748746
[TBL] [Abstract][Full Text] [Related]
6. Defense of Elevated Body Weight Setpoint in Diet-Induced Obese Rats on Low Energy Diet Is Mediated by Loss of Melanocortin Sensitivity in the Paraventricular Hypothalamic Nucleus.
Luchtman DW; Chee MJ; Doslikova B; Marks DL; Baracos VE; Colmers WF
PLoS One; 2015; 10(10):e0139462. PubMed ID: 26444289
[TBL] [Abstract][Full Text] [Related]
7. Hypothalamic actions of neuromedin U.
Wren AM; Small CJ; Abbott CR; Jethwa PH; Kennedy AR; Murphy KG; Stanley SA; Zollner AN; Ghatei MA; Bloom SR
Endocrinology; 2002 Nov; 143(11):4227-34. PubMed ID: 12399416
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous activity, economy of activity, and resistance to diet-induced obesity in rats bred for high intrinsic aerobic capacity.
Novak CM; Escande C; Burghardt PR; Zhang M; Barbosa MT; Chini EN; Britton SL; Koch LG; Akil H; Levine JA
Horm Behav; 2010 Aug; 58(3):355-67. PubMed ID: 20350549
[TBL] [Abstract][Full Text] [Related]
9. Chronic administration of brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus reverses obesity induced by high-fat diet.
Wang C; Godar RJ; Billington CJ; Kotz CM
Am J Physiol Regul Integr Comp Physiol; 2010 May; 298(5):R1320-32. PubMed ID: 20164202
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of hypothalamic CART mRNA in response to body weight change following different dietary interventions.
Yu Y; South T; Wang Q; Huang XF
Neurochem Int; 2008 Jun; 52(8):1422-30. PubMed ID: 18455834
[TBL] [Abstract][Full Text] [Related]
11. Weight gain model in prepubertal rats: prediction and phenotyping of obesity-prone animals at normal body weight.
Leibowitz KL; Chang GQ; Pamy PS; Hill JO; Gayles EC; Leibowitz SF
Int J Obes (Lond); 2007 Aug; 31(8):1210-21. PubMed ID: 17471301
[TBL] [Abstract][Full Text] [Related]
12. Orexin A (hypocretin 1) injected into hypothalamic paraventricular nucleus and spontaneous physical activity in rats.
Kiwaki K; Kotz CM; Wang C; Lanningham-Foster L; Levine JA
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E551-9. PubMed ID: 14656716
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus increases energy expenditure by elevating metabolic rate.
Wang C; Bomberg E; Billington C; Levine A; Kotz CM
Am J Physiol Regul Integr Comp Physiol; 2007 Sep; 293(3):R992-1002. PubMed ID: 17567712
[TBL] [Abstract][Full Text] [Related]
14. The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2).
Peier A; Kosinski J; Cox-York K; Qian Y; Desai K; Feng Y; Trivedi P; Hastings N; Marsh DJ
Endocrinology; 2009 Jul; 150(7):3101-9. PubMed ID: 19324999
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of neuromedin U actions in energy homeostasis and pituitary function.
Ivanov TR; Lawrence CB; Stanley PJ; Luckman SM
Endocrinology; 2002 Oct; 143(10):3813-21. PubMed ID: 12239092
[TBL] [Abstract][Full Text] [Related]
16. Comparison of feeding suppression by the anorexigenic hormones neuromedin U and neuromedin S in rats.
Nakahara K; Katayama T; Maruyama K; Ida T; Mori K; Miyazato M; Kangawa K; Murakami N
J Endocrinol; 2010 Nov; 207(2):185-93. PubMed ID: 20732934
[TBL] [Abstract][Full Text] [Related]
17. Central effects of neuromedin U in the regulation of energy homeostasis.
Nakazato M; Hanada R; Murakami N; Date Y; Mondal MS; Kojima M; Yoshimatsu H; Kangawa K; Matsukura S
Biochem Biophys Res Commun; 2000 Oct; 277(1):191-4. PubMed ID: 11027662
[TBL] [Abstract][Full Text] [Related]
18. Elevated hypothalamic orexin signaling, sensitivity to orexin A, and spontaneous physical activity in obesity-resistant rats.
Teske JA; Levine AS; Kuskowski M; Levine JA; Kotz CM
Am J Physiol Regul Integr Comp Physiol; 2006 Oct; 291(4):R889-99. PubMed ID: 16763079
[TBL] [Abstract][Full Text] [Related]
19. Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway.
Hanada R; Teranishi H; Pearson JT; Kurokawa M; Hosoda H; Fukushima N; Fukue Y; Serino R; Fujihara H; Ueta Y; Ikawa M; Okabe M; Murakami N; Shirai M; Yoshimatsu H; Kangawa K; Kojima M
Nat Med; 2004 Oct; 10(10):1067-73. PubMed ID: 15448684
[TBL] [Abstract][Full Text] [Related]
20. Central Sirt1 regulates body weight and energy expenditure along with the POMC-derived peptide α-MSH and the processing enzyme CPE production in diet-induced obese male rats.
Cyr NE; Steger JS; Toorie AM; Yang JZ; Stuart R; Nillni EA
Endocrinology; 2014 Jul; 155(7):2423-35. PubMed ID: 24773342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
